Search

Your search keyword '"Klein-Mascia, Kendra"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Klein-Mascia, Kendra" Remove constraint Author: "Klein-Mascia, Kendra"
14 results on '"Klein-Mascia, Kendra"'

Search Results

2. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

3. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

4. Durability and Efficacy of Faricimab in Treatment‐Resistant Retinal Edema Utilizing "Real‐World" Dosing Regimens.

5. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

6. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

7. TENAYA and LUCERNE

8. Faricimab Treat-and-Extend for Diabetic Macular Edema

9. Man presents with progressive blurred vision in left eye.

10. Man with complicated history presents for retina consultation.

11. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

12. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

13. Woman presents with unilateral, painless vision loss.

14. Woman presents with amelanotic deep mass in left eye.

Catalog

Books, media, physical & digital resources